PDI Inc (NASDAQ:PDII)

1.27
Delayed Data
As of May 22
 +0.02 / +1.60%
Today’s Change
1.00
Today|||52-Week Range
5.05
-29.05%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$20.6M

Company Description

PDI, Inc. provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the U. S. It also provides other promotional services including clinical educator services, digital communications, teledetailing and with the formation of its new business unit, Interpace BioPharma which provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. The company operates its business through the following segments: Commercial Services and Interpace Diagnostics. The Commercial Services segment focuses on providing outsourced pharmaceutical, biotechnology, medical device and diagnostic sales teams to corporate customers. The Interpace Diagnostics segment focuses on developing an commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.

Contact Information

PDI, Inc.
Morris Corporate Center 1 Building A
Parsippany New Jersey 07054
P:(800) 242-7494
Investor Relations:

Employees

Shareholders

Individual stakeholders51.25%
Other institutional20.26%
Mutual fund holders19.47%

Top Executives

Nancy Sue LurkerChief Executive Officer & Director
Graham G. MiaoChief Financial Officer, Treasurer & Executive VP
Rhonda De StefanoVice President & Associate General Counsel
Patrick K. KaneVice President & Controller
Steve RynkowskiVP-Learning, Development & Commercial Operations

To view my watchlist

Not a member yet?

Sign up now for a free account